567565

Sodium Stibogluconate

A pentavalent antimony compound that irreversibly inhibits protein tyrosine phosphatase (PTPase) activity, including Src homology PTPase-1 (SHP-1) (99% inhibition at ~11 µM) by forming a stable complex.

• Synonim(y): Sodium Stibogluconate, SSG, Antimony Sodium Gluconate, NaSb^v, PTP Inhibitor XXIV, SHP1 Inhibitor IV
• Wzór empiryczny (zapis Hilla): C₁₂H₁₇O₁₇Sb₂ · 3Na · 9H₂O
• Numer CAS: 16037-91-5
• Masa cząsteczkowa: 907.88
• MDL number: MFCD01746582
• UNSPSC Code: 12352200
• NACRES: NA.77
• Assay: ≥90% dry basis (≥30% Sb content, titration)
• Form: solid
• Storage condition: OK to freeze, desiccated, protect from light

Właściwości

• Quality Segment: 100
• description: Merck USA index - 14, 701
• assay: ≥90% dry basis (≥30% Sb content, titration)
• form: solid
• manufacturer/tradename: Calbiochem^®
• storage condition: OK to freeze, desiccated, protect from light
• color: white
• solubility: water: 1 mg/mL
• shipped in: ambient
• storage temp.: 2-8°C
• SMILES string: [Sb]2(=O)(O[C@@H]([C@@H]([C@@H](O2)C(=O)[O-])O)[C@H](O)CO)O[Sb]1(=O)O[C@@H]([C@@H]([C@@H](O1)C(=O)[O-])O)[C@H](O)CO.[Na+].[Na+].[Na+].O.O.O.O.O.O.O.O.O
• InChI: 1S/2C6H10O7.3Na.9H2O.3O.2Sb/c2*7-1-2(8)3(9)4(10)5(11)6(12)13;;;;;;;;;;;;;;;;;/h2*2-5,7-8,10H,1H2,(H,12,13);;;;9*1H2;;;;;/q2*-2;3*+1;;;;;;;;;;;;;2*+2/p-2/t2*2-,3-,4+,5-;;;;;;;;;;;;;;;;;/m11................./s1
• InChI key: CUEDNFKBTFCOSV-UZVLBLASSA-L

Opis

General description

A pentavalent antimony compound that forms a stable complex with and irreversibly inhibits Src homology protein tyrosine phosphatase (SHP-1) (99% inhibition at 11 µM). Also inhibits SHP-2 and PTP1B at an ~10-fold higher concentration (~110 µM). Does not inhibit the dual specificity protein tyrosine phosphatase (PTPase) or mitogen-activated protein kinase phosphatase-1 (MKP-1). Reported to induce general protein tyrosine phosphorylation and enhance IL-3-induced protein tyrosine phosphorylation of Jak2 and Stat5 in Baf3 cells. Also reported to augment IL-3-induced proliferation in Baf3 cells (EC_max = 44 µM) and GM-CSF-induced proliferation in TF-1 cells (EC_max = 55 µM). Exhibits anti-leishmanial effects.

A pentavalent antimony compound that irreversibly inhibits protein tyrosine phosphatase (PTPase) activity, including Src homology PTPase-1 (SHP-1) (99% inhibition at ~11 µM) by forming a stable complex. At higher concentrations (~110 µM), it inhibits SHP-2 and PTP1B activities.

Biochem/physiol Actions

Cell permeable: no

Primary Target
PTPase activity, including Src homology PTPase-1 (SHP-1)

Product does not compete with ATP.

Reversible: yes

Target IC₅₀: ~11 µM causing 99% inhibition of protein tyrosine phosphatase (PTPase) activity, including Src homology PTPase-1 (SHP-1)

Packaging

Packaged under inert gas

Preparation Note

Heating to 75°C with constant stirring or constant stirring overnight at room temperature may be required for complete solubilization.

Unstable in solution; reconstitute just prior to use.

Other Notes

Wortmann, G., et al. 2002. Clin. Infect. Dis.35, 261.
Pathak, M.K. and Yi, T. 2001. J. Immunol.167, 3391.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Standard Handling (A)

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• pictograms: GHS07,GHS09
• signalword: Warning
• hcodes: H302 + H332,H411
• pcodes: P261 - P264 - P271 - P273 - P301 + P312 - P304 + P340 + P312
• Hazard Classifications: Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2
• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable